The MarketWatch News Department was not involved in the creation of this content. -- Able Medical exceeds 10,000 U.S. procedures since the release of the Valkyrie(R) Thoracic Fixation System.* -- Over ...
Able Medical exceeds 10,000 U.S. procedures since the release of the Valkyrie® Thoracic Fixation System.* Over 150 hospitals use the new Valkyrie Thoracic Fixation System, consistently representing ...
Able Medical, a leading global medical device company focused on sternal fixation, announced the completion of the 10,000th procedure in the U.S. with the Valkyrie Thoracic Fixation System. The system ...
Over 150 hospitals use the new Valkyrie Thoracic Fixation System, consistently representing competitive conversions and repeat users. Valkyrie Thoracic Fixation System is the market’s first single-use ...
In a new study published in Engineering, academician Yingze Zhang's research team introduces the Proximal Femur Bionic Nail (PFBN) as a potential panacea for unstable intertrochanteric femur fractures ...
New Jersey Medicare patients will be guinea pigs in a grand experiment that tests the capabilities of using artificial intelligence to decide which medical procedures should be covered by insurance.
The University of Washington basketball team takes a road trip on Friday night that every college entry should envy. The Huskies get on a bus and go 4.8 miles across town, from Alaska Airlines Arena ...
Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results